MiniMed Group is trading at $17.64, down 4.16%; available reporting does not establish a cause for the decline. - On October 14, Medtronic announced it would exchange its remaining 252,813,348 MiniMed shares, leaving it with no stake. The offer was oversubscribed, focusing attention on share supply. - Healthcare was reportedly higher, while broad-market readings were mixed; no live volume figure was provided. - Rothschild Redburn’s Buy rating and $30 target are supportive, but do not explain the drop.